S100A8/A9 stimulates breast cancer progression by activating key signaling pathways, such as IL-6-JAK2-STAT3, TNF-α-CXCL1/2, TGF-β, NF-κB, and MAPK (12, 13). This evidence concerns the gene S100A8 and breast carcinoma.